(RTTNews) - Quest Diagnostics (DGX), a diagnostic information services provider, announced Wednesday that its AAVrh74 ELISA assay (CDx) has been granted Breakthrough Device Designation from the U.S.
This article is forms part of a special issue on "research on prevention and control of emerging infectious diseases" https://www.sciencedirect.com/journal/biosafety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results